<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="pone.0199453.t002" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.pone.0199453.t002</object-id>
 <label>Table 2</label>
 <caption>
  <title>Projected impact, costs and savings from the VMMC program in a 'status quo' background context, relative to the counterfactual scenario of no VMMC program ever.</title>
 </caption>
 <alternatives>
  <graphic id="pone.0199453.t002g" xlink:href="pone.0199453.t002" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <table frame="hsides" rules="groups">
   <colgroup span="1">
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
   </colgroup>
   <thead>
    <tr>
     <th align="left" rowspan="1" colspan="1">Scenario</th>
     <th align="left" rowspan="1" colspan="1">Outcome</th>
     <th align="left" rowspan="1" colspan="1">Goals model
      <xref ref-type="table-fn" rid="t002fn002">
       <sup>a</sup>
      </xref>
     </th>
     <th align="left" rowspan="1" colspan="1">ICL model
      <xref ref-type="table-fn" rid="t002fn003">
       <sup>b</sup>
      </xref>
     </th>
     <th align="left" rowspan="1" colspan="1">EMOD model
      <xref ref-type="table-fn" rid="t002fn002">
       <sup>a</sup>
      </xref>
      <sup>,</sup>
      <xref ref-type="table-fn" rid="t002fn004">
       <sup>c</sup>
      </xref>
     </th>
    </tr>
   </thead>
   <tbody>
    <tr>
     <td align="left" rowspan="4" colspan="1">Results over 2009–2016</td>
     <td align="left" rowspan="1" colspan="1">Number of VMMCs performed</td>
     <td align="left" rowspan="1" colspan="1">845,500</td>
     <td align="left" rowspan="1" colspan="1">845,428</td>
     <td align="left" rowspan="1" colspan="1">891,500</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Number of HIV infections averted</td>
     <td align="left" rowspan="1" colspan="1">12,200 (2%)</td>
     <td align="left" rowspan="1" colspan="1">7,200 (1.6%)</td>
     <td align="left" rowspan="1" colspan="1">2,600 (0.5%)</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Number of VMMCs per infection averted</td>
     <td align="left" rowspan="1" colspan="1">69</td>
     <td align="left" rowspan="1" colspan="1">115</td>
     <td align="left" rowspan="1" colspan="1">335</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Cost per infection averted</td>
     <td align="left" rowspan="1" colspan="1">$7,600</td>
     <td align="left" rowspan="1" colspan="1">$12,600</td>
     <td align="left" rowspan="1" colspan="1">$36,500</td>
    </tr>
    <tr>
     <td align="left" rowspan="4" colspan="1">Results 2009–2030; scenario Program ends after 2016</td>
     <td align="left" rowspan="1" colspan="1">Number of VMMCs performed</td>
     <td align="left" rowspan="1" colspan="1">845,500</td>
     <td align="left" rowspan="1" colspan="1">845,428</td>
     <td align="left" rowspan="1" colspan="1">891,500</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Number of HIV infections averted</td>
     <td align="left" rowspan="1" colspan="1">69,800 (5%)</td>
     <td align="left" rowspan="1" colspan="1">24,400 (2.3%)</td>
     <td align="left" rowspan="1" colspan="1">52,250 (4%)</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Number of VMMCs per infection averted</td>
     <td align="left" rowspan="1" colspan="1">12</td>
     <td align="left" rowspan="1" colspan="1">34</td>
     <td align="left" rowspan="1" colspan="1">17</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Cost per infection averted</td>
     <td align="left" rowspan="1" colspan="1">$1,320</td>
     <td align="left" rowspan="1" colspan="1">$3,700</td>
     <td align="left" rowspan="1" colspan="1">$1,860</td>
    </tr>
    <tr>
     <td align="left" rowspan="4" colspan="1">Results 2009–2030; scenario Program ends after 2018/19</td>
     <td align="left" rowspan="1" colspan="1">Number of VMMCs performed</td>
     <td align="left" rowspan="1" colspan="1">1,777,000</td>
     <td align="left" rowspan="1" colspan="1">1,515,900</td>
     <td align="left" rowspan="1" colspan="1">1,262,000</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Number of HIV infections averted</td>
     <td align="left" rowspan="1" colspan="1">126,000 (10%)</td>
     <td align="left" rowspan="1" colspan="1">37,500 (3.5%)</td>
     <td align="left" rowspan="1" colspan="1">71,000 (6%)</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Number of VMMCs per infection averted</td>
     <td align="left" rowspan="1" colspan="1">14</td>
     <td align="left" rowspan="1" colspan="1">40</td>
     <td align="left" rowspan="1" colspan="1">18</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Cost per infection averted</td>
     <td align="left" rowspan="1" colspan="1">$1,500</td>
     <td align="left" rowspan="1" colspan="1">$4,400</td>
     <td align="left" rowspan="1" colspan="1">$1,900</td>
    </tr>
    <tr>
     <td align="left" rowspan="5" colspan="1">Results 2009–2030; scenario Program targets through 2021 met and maintained</td>
     <td align="left" rowspan="1" colspan="1">Number of VMMCs performed</td>
     <td align="left" rowspan="1" colspan="1">3,257,000</td>
     <td align="left" rowspan="1" colspan="1">3,158,000</td>
     <td align="left" rowspan="1" colspan="1">3,210,000</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Number of HIV infections averted</td>
     <td align="left" rowspan="1" colspan="1">171,000 (13%)</td>
     <td align="left" rowspan="1" colspan="1">128,000 (12%)</td>
     <td align="left" rowspan="1" colspan="1">108,000 (10%)</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Number of VMMCs per infection averted</td>
     <td align="left" rowspan="1" colspan="1">19</td>
     <td align="left" rowspan="1" colspan="1">25</td>
     <td align="left" rowspan="1" colspan="1">30</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Cost per infection averted</td>
     <td align="left" rowspan="1" colspan="1">$2,100</td>
     <td align="left" rowspan="1" colspan="1">$2,700</td>
     <td align="left" rowspan="1" colspan="1">$3,250</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Savings in ART costs, 2017–2030</td>
     <td align="left" rowspan="1" colspan="1">$198 million</td>
     <td align="left" rowspan="1" colspan="1">$55 million</td>
     <td align="left" rowspan="1" colspan="1">$158 million</td>
    </tr>
   </tbody>
  </table>
 </alternatives>
 <table-wrap-foot>
  <fn id="t002fn001">
   <p>The percentages in parentheses represent the proportion of new HIV infections averted relative to the number of new HIV infections in the counterfactual scenario.</p>
  </fn>
  <fn id="t002fn002">
   <p>
    <sup>a</sup> Health and cost-effectiveness outcomes are for all ages
   </p>
  </fn>
  <fn id="t002fn003">
   <p>
    <sup>b</sup> Health and cost-effectiveness outcomes are for age 15–49 years only
   </p>
  </fn>
  <fn id="t002fn004">
   <p>
    <sup>c</sup> Over this short time period, EMOD outcomes are influenced by noise from stochastic variation.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
